ArticleCureus2025
Systemic Lupus Erythematosus (SLE) Complicated by Human Immunodeficiency Virus (HIV): A Rare and Challenging Association.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder characterized by multi-organ inflammation, while human immunodeficiency virus (HIV) primarily compromises host defense by depleting CD4+ T lymphocytes. The pathogenesis of SLE involves dysregulated immunity with autoantibody and immune complex formation, whereas HIV-induced immunosuppression paradoxically predisposes individuals to autoimmune phenomena. The complex interplay between HIV and SLE remains poorly understood, highlighting the importance of accurate differentiation and individualized management in patients affected by both conditions and collaborative management across specialties. We report the case of a 41-year-old male with a three-year history of SLE and suspected lupus nephritis, who had declined a renal biopsy. He later presented with clinical features suggestive of HIV infection. The case underscores the challenges of balancing immunosuppressive therapy in the setting of concomitant autoimmune disease and viral immunodeficiency. The patient was successfully managed with the antiretroviral regimen of dolutegravir and lamivudine, while continuing hydroxychloroquine and corticosteroids. Rituximab was discontinued due to safety concerns and potential drug interactions, considering the benefits of hydroxychloroquine and steroids in managing specific conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.